Catalyst Wire Dossier Catalyst Wire Dossier

LCP-Tacro

tacrolimus · Veloxis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for LCP-Tacro, covering 2015-05-08 to 2020-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day. [Phase 4]

See pricing